Clinical study of Xiaoshuan enteric-soluble capsule in the treatment of ischemic stroke
- Conditions
- stroke
- Registration Number
- ITMCTR2024000096
- Lead Sponsor
- Shanxi University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- Not specified
1. Patients who meet the diagnosis of acute cerebral infarction and are confirmed by CT or MRI;
2. NIHSS score: 4-15 (including 4 and 15 points);
3. Patients aged between 35 and 75 years;
4. Onset time within 7 days;
5. Patients with stable vital signs, clear consciousness and no serious complications;
6. Patients with first onset or previous history of stroke without limb paralysis and other sequelae;
7. Good compliance with this study;
8. Patients or family members sign informed consent.
1.In the TOAST classification, patients with cerebral infarction caused by other causes other than atherosclerosis;
2. Patients with progressive cerebral infarction or recurrent recurrent cerebral infarction;
3. Patients with severe cardiovascular diseases, liver and kidney dysfunction, and respiratory diseases;
4. Hemorrhagic disease;
5. Pregnant and lactating patients;
6.Patients who received thrombolytic therapy or mechanical thrombectomy in this hospital;
7. Patients with hearing and other dysfunction who cannot cooperate with the assessment;
8. Participated in other clinical trials within the last 90 days.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method